<code id='BD12EAECD2'></code><style id='BD12EAECD2'></style>
    • <acronym id='BD12EAECD2'></acronym>
      <center id='BD12EAECD2'><center id='BD12EAECD2'><tfoot id='BD12EAECD2'></tfoot></center><abbr id='BD12EAECD2'><dir id='BD12EAECD2'><tfoot id='BD12EAECD2'></tfoot><noframes id='BD12EAECD2'>

    • <optgroup id='BD12EAECD2'><strike id='BD12EAECD2'><sup id='BD12EAECD2'></sup></strike><code id='BD12EAECD2'></code></optgroup>
        1. <b id='BD12EAECD2'><label id='BD12EAECD2'><select id='BD12EAECD2'><dt id='BD12EAECD2'><span id='BD12EAECD2'></span></dt></select></label></b><u id='BD12EAECD2'></u>
          <i id='BD12EAECD2'><strike id='BD12EAECD2'><tt id='BD12EAECD2'><pre id='BD12EAECD2'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:9
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Pfizer highlights cancer drugs it thinks could reignite investor interest
          Pfizer highlights cancer drugs it thinks could reignite investor interest

          AscreenattheNewYorkStockExchangelastNovember.MichaelM.Santiago/GettyImagesPfizerspentmorethanfourhou

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          STAT Readout Newsletter: Today's biggest biotech updates

          Photoillustration:STATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiot